Aziz Sawaf insider trades

Open-market stock purchases and sales by Aziz Sawaf, SVP & CHIEF FINANCIAL OFFICER at Theravance Biopharma, Inc, from SEC Form 4 filings since Feb 20, 2023.

Recent trades

DateStockTradeValue
Sep 23, 2026TBPH Theravance Biopharma, IncSold (not open market)—
Sep 23, 2026TBPH Theravance Biopharma, IncSold (not open market)—
Sep 23, 2026TBPH Theravance Biopharma, IncSold (not open market)—
Aug 20, 2026TBPH Theravance Biopharma, IncSold (not open market)$137K
May 20, 2026TBPH Theravance Biopharma, IncSold (not open market)$143K
Apr 1, 2026TBPH Theravance Biopharma, IncBought (not open market)—
Feb 20, 2026TBPH Theravance Biopharma, IncSold (not open market)$406K
Nov 20, 2025TBPH Theravance Biopharma, IncSold (not open market)$333K

Companies traded

  • TBPH Theravance Biopharma, Inc: other filings, last Sep 23, 2026

Get free alerts when Aziz Sawaf files a new trade →